ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1699

Obesity and Pediatric Psoriatic Arthritis

Cynthia Manos1, Timothy Brandon2, Rui Xiao3, Jon M. Burnham4 and Pamela F. Weiss1, 1Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 2Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, 3Department of Pediatrics, Division of Biostatistics, Children's Hospital of Philadelphia, Philadelphia, PA, 4Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: obesity, pediatrics and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Spondylarthropathies and Psoriatic Arthritis - Comorbidities and Treatment Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:   Studies in adults have shown a significant association between obesity and psoriatic arthritis. The association of obesity with pediatric psoriatic arthritis is unknown. We aimed to evaluate the prevalence of obesity in a pediatric psoriatic arthritis cohort.

Methods: We conducted a retrospective cross-sectional study of children with psoriatic arthritis evaluated at a single center between 6/2010 and 9/2014.  The cohort consisted of children with an ICD-9-CM code of 696.0 “Psoriatic arthritis” given at diagnosis or a subsequent follow-up visit. Age- and sex-specific Z-scores for weight, height, and body mass index (BMI) were calculated based on the 2000 CDC Growth data.  Overweight or obese was defined as a BMI greater than or equal to the 85th and 95thpercentile, respectively. Differences in clinical and demographic characteristics who were overweight and not overweight were assessed using Wilcoxon rank sum test, t-test or chi-squared test, as appropriate. The association of age, sex, active joint count, and presence of psoriasis with being overweight was tested using univariate logistic regression. The reference population consisted of 909 healthy participants recruited from general pediatric clinics in the surrounding community for multiple studies done by the Nutrition and Growth laboratory at our institution.

Results: During the study period 48 children with psoriatic arthritis were evaluated. 34 (71%) were female and 17 (35.4%) had a first-degree relative with psoriasis.  29 (60.4%) and 19 (39.6%) of children had psoriasis or dactylitis at diagnosis, respectively. 3 (6.3%) and 5 (10.4%) of the children with psoriatic arthritis were overweight or obese, respectively. Mean BMI z-scores for children with psoriatic arthritis and the reference group were 0.40 (SD 0.96) and 0.36 (SD 1.01), respectively. In comparison to the reference population the proportion of children with psoriatic arthritis who were overweight was not statistically different (0.30 versus 0.17; p=0.06). Comparison of demographics and clinical features between those children with psoriatic arthritis who were overweight and not overweight are shown in the Table. In univariate logistic regression, female sex was associated with significantly decreased odds of being overweight (Odds ratio: 0.17, 95% CI: 0.03 to 0.87). Age, disease duration, psoriasis, dactylitis, and active joint count at diagnosis were not significantly associated with being overweight.

Conclusion: 17% of our psoriatic arthritis cohort was overweight or obese. Female sex was associated with decreased odds of being overweight. The lack of association of obesity with pediatric psoriatic arthritis may be secondary to our limited sample size or may be reflective of true differences in pediatric and adult disease.

Table. Comparison of demographic and clinical features of children who were not overweight and those who were overweight or obese

 

All

N= 48

Overweight or obese

N= 8

Not-overweight

N= 40

p-value

Age in years, mean (SD)

12.2 (4.8)

12.2 (5.1)

12.0 (3.2)

0.92

Female sex, N (%)

34 (71)

3 (0.38)

31 (0.78)

0.02

Disease duration in years, mean (SD)

5.0 (4.2)

1.8 (3.1)

3.7 (3.9)

0.20

Psoriasis, N (%)

29 (60.4)

4 (50.0)

25 (62.5)

0.44

Dactylitis, N (%)

19 (39.6)

4 (50)

15 (37.5)

0.51

Active joint count^, median (IQR)

3 (1-7)

2.5 (1-4)

3 (1-7.5)

0.54

Legend ^active joint count at diagnosis


Disclosure: C. Manos, None; T. Brandon, None; R. Xiao, None; J. M. Burnham, None; P. F. Weiss, None.

To cite this abstract in AMA style:

Manos C, Brandon T, Xiao R, Burnham JM, Weiss PF. Obesity and Pediatric Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/obesity-and-pediatric-psoriatic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/obesity-and-pediatric-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology